| Article ID | Journal | Published Year | Pages | File Type | 
|---|---|---|---|---|
| 6143781 | American Journal of Obstetrics and Gynecology | 2016 | 25 Pages | 
Abstract
												Cervical length screening and treatment with progesterone is a not a dominant, cost-effective strategy unless progesterone is more effective than has been suggested by available data for US women. Until future trials demonstrate greater progesterone efficacy, and effectiveness studies confirm a benefit from screening and treatment, the cost-effectiveness of universal cervical length screening in the United States remains questionable.
											Related Topics
												
													Health Sciences
													Medicine and Dentistry
													Medicine and Dentistry (General)
												
											Authors
												Siddharth MBBS, MPH, Meredith PhD, MSPH, Rodney K. MD, MS, John MD, MSPH, 
											